Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Callen JP. Dermatomyositis. Lancet. 2000;355:53–7.
2. •• Marie I, Hatron PY, Dominique S, et al. Short term and long term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum. 2011;63:3439–47. This was a multicenter study evaluating both the long-term outcome of and therapy for ILD in 107 PM/DM patients. This study also looked at the predictive factors for ILD deterioration in PM/DM.
3. Marie I, Hachulla E, Levesque H, et al. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol. 1999;26:2706–9.
4. Marie I, Hachulla E, Hatron PY, et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors. J Rheumatol. 2001;28:2230–7.
5. Marie I, Hatron PY, Levesque H, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore). 1999;78:139–47.
Cited by
181 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献